Home » Newsletters » BioWorld Science

BioWorld Science

March 21, 2022

View Archived Issues

Immune suppressive glycoprotein-targeting MAb reported

CAP2 is increased in patients with AD and correlates with tau pathology

PP2B inhibition clears tau toxicity in experimental AD

Amyloid beta 42 impacts the expression of SPPL2B in AD

Anc80L65 vector combined with new surgical technique for hearing loss gene therapy

OLX-07010 shows promising efficacy in mouse models of tauopathy

TREM2 agonistic MAb attenuates tau burden and neurodegeneration

Researchers develop new murine model of AD

Sorrento reports findings with universal chimeric mRNA based COVID-19 vaccine

ALS Therapy Development Institute patents new compounds for ALS

Merck & Co. synthesizes new anti-HIV compounds

MagicMed Industries presents 5-HT2A receptor agonists

Incyte divulges new JAK2 inhibitors

Vertex Pharmaceuticals synthesizes new APOL1 inhibitors

Volastra collaborates with Bristol Myers Squibb to discover and develop oncology drug candidates

Grant supports Neuromagen's development of AGS-499 for ALS

Ixaka expands IP portfolio to allow use of TNP gene delivery platform across multiple areas

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...